Literature DB >> 20001341

Analysing the expression of protein kinase C eta in human hepatocellular carcinoma.

Hsiu-Chin Lu1, Fen-Pi Chou, Kun-Tu Yeh, Ya-Sian Chang, Nicholas C Hsu, Jan-Gowth Chang.   

Abstract

AIMS: Protein kinase Cs (PKCs) play important roles in cell proliferation, differentiation, apoptosis, migration and tumorigenesis. In this report, we investigated the expression of PKCeta in human hepatocellular carcinoma (HCC) tissues and explored its role in the development of HCC.
METHODS: We used real-time quantitative RT-PCR, mutation analysis, and immunohistochemical staining to analyse the expression of PKCeta in 50 pairs of human hepatocellular carcinoma (HCC) tissues.
RESULTS: Expression of PKCeta was down-regulated in 82% of HCC tissues and the reduction of PKCeta was associated with poorer long-term survival of HCC patients.
CONCLUSION: Reduced expression of PKCeta may represent a molecular lesion in the development of more aggressive disease of HCC.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20001341     DOI: 10.3109/00313020903273076

Source DB:  PubMed          Journal:  Pathology        ISSN: 0031-3025            Impact factor:   5.306


  10 in total

Review 1.  Protein kinase C as a tumor suppressor.

Authors:  Alexandra C Newton
Journal:  Semin Cancer Biol       Date:  2017-05-02       Impact factor: 15.707

Review 2.  Protein kinase C: perfectly balanced.

Authors:  Alexandra C Newton
Journal:  Crit Rev Biochem Mol Biol       Date:  2018-04       Impact factor: 8.250

3.  Novel regulation of protein kinase C-η.

Authors:  Deepanwita Pal; Shalini Persaud Outram; Alakananda Basu
Journal:  Biochem Biophys Res Commun       Date:  2012-08-07       Impact factor: 3.575

4.  Cancer-associated protein kinase C mutations reveal kinase's role as tumor suppressor.

Authors:  Corina E Antal; Andrew M Hudson; Emily Kang; Ciro Zanca; Christopher Wirth; Natalie L Stephenson; Eleanor W Trotter; Lisa L Gallegos; Crispin J Miller; Frank B Furnari; Tony Hunter; John Brognard; Alexandra C Newton
Journal:  Cell       Date:  2015-01-22       Impact factor: 41.582

5.  Upregulation of PKCη by PKCε and PDK1 involves two distinct mechanisms and promotes breast cancer cell survival.

Authors:  Deepanwita Pal; Shalini Persaud Outram; Alakananda Basu
Journal:  Biochim Biophys Acta       Date:  2013-04-04

6.  Role of ellagic acid in regulation of apoptosis by modulating novel and atypical PKC in lymphoma bearing mice.

Authors:  Sudha Mishra; Manjula Vinayak
Journal:  BMC Complement Altern Med       Date:  2015-08-15       Impact factor: 3.659

7.  miR-24-3p Suppresses Malignant Behavior of Lacrimal Adenoid Cystic Carcinoma by Targeting PRKCH to Regulate p53/p21 Pathway.

Authors:  Ming-Xue Zhang; Jie Zhang; Hong Zhang; Hua Tang
Journal:  PLoS One       Date:  2016-06-28       Impact factor: 3.240

8.  Development and validation of a new tumor-based gene signature predicting prognosis of HBV/HCV-included resected hepatocellular carcinoma patients.

Authors:  Gui-Qi Zhu; Yi Yang; Er-Bao Chen; Biao Wang; Kun Xiao; Shi-Ming Shi; Zheng-Jun Zhou; Shao-Lai Zhou; Zheng Wang; Ying-Hong Shi; Jia Fan; Jian Zhou; Tian-Shu Liu; Zhi Dai
Journal:  J Transl Med       Date:  2019-06-18       Impact factor: 5.531

9.  Activation of PKC supports the anticancer activity of tigilanol tiglate and related epoxytiglianes.

Authors:  Jason K Cullen; Glen M Boyle; Pei-Yi Yap; Stefan Elmlinger; Jacinta L Simmons; Natasa Broit; Jenny Johns; Blake Ferguson; Lidia A Maslovskaya; Andrei I Savchenko; Paul Malek Mirzayans; Achim Porzelle; Paul V Bernhardt; Victoria A Gordon; Paul W Reddell; Alberto Pagani; Giovanni Appendino; Peter G Parsons; Craig M Williams
Journal:  Sci Rep       Date:  2021-01-08       Impact factor: 4.379

10.  Pan-Cancer Study on Protein Kinase C Family as a Potential Biomarker for the Tumors Immune Landscape and the Response to Immunotherapy.

Authors:  Alaa Abdelatty; Qi Sun; Junhong Hu; Fubing Wu; Guanqun Wei; Haojun Xu; Guoren Zhou; Xiaoming Wang; Hongping Xia; Linhua Lan
Journal:  Front Cell Dev Biol       Date:  2022-01-31
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.